Recent Data on HIV Therapies and Treatment Paradigms
Target Audience
Learning Objectives
- Utilize current and emerging HIV therapies and treatment paradigms to improve their treatment of HIV-positive patients;
- Evaluate and apply criteria for evaluating current and emerging HIV therapies and treatment paradigms;
- Assess and discuss the latest data on HIV therapies and treatment paradigms;
- Compare and contrast major ARV guidelines recommendations with emerging HIV therapies and treatment paradigms and discuss the relative advantages and disadvantages;
- Discuss future directions in HIV treatment and research.
- 0.75 AMA PRA Category 1 Credit™
- 0.75 Participation
CO-DIRECTORS
Interim Chair, Department of Medicine
Chief, Division of HIV Medicine Harbor-UCLA Medical Center
Professor of Medicine,
David Geffen School of Medicine at UCLA
Los Angeles, CA
Professor of Medicine, School of Medicine Chief
Division of Infectious Diseases
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
FACULTY
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois
Adjunct Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Washington, DC
Director HIV Clinical Services
Philadelphia Department of Public Health
Ambulatory Health Services
Philadelphia, Pennsylvania
Professor of Medicine Hospital of the University of Pennsylvania
Director, Adult AIDS Clinical Trials Unit (ACTU)
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and ViralEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Health Professions Credit
Please Note: The credit claiming process will close three months after the activity end date. Requests to claim credit after three months will be subject to additional fees.